Developer of pharmaceutical molecular entities, formulations and active pharmaceutical ingredients created to deal with issues of child health care. The company's pharmaceutical molecular entities, formulations and active pharmaceutical ingredients offer generic drugs manufactured in the US, Argentina, Czech Republic and India, enabling patients to be treated for conditions such as inflammation, pain and oncology.read more
Glenmark Pharmaceuticals CEO & Leadership Team Ratings
The Leadership Score of 87/100 is based on 15 ratings; it combines employee feedback on their CEO (65/100), Manager (88/100), and Executive Team (80/100).
Glenmark Pharmaceuticals CEO Rating
Bottom 35% Compared to other companies of similar size
C-
65/ 100
The CEO of Glenmark Pharmaceuticals received an average score of 65 from Glenmark Pharmaceuticals employees.
Glenmark Pharmaceuticals Manager Rating
Top 5% Compared to other companies of similar size
A+
88/ 100
Managers received an average score of 88 from Glenmark Pharmaceuticals employees.
Glenmark Pharmaceuticals Executive Team Rating
Top 25% Compared to other companies of similar size
B
80/ 100
The Executive team received an average score of 80 from Glenmark Pharmaceuticals employees.